Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling.
Brain characterization using normalized quantitative magnetic resonance imaging.
Kalopanaxsaponin A Exerts Anti-Inflammatory Effects in Lipopolysaccharide-Stimulated Microglia via Inhibition of JNK and NF-κB/AP-1 Pathways.
Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications.
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair.
Patient-specific early classification of multivariate observations.
Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis.
[Future issues of the multiple sclerosis treatment from a medical economic viewpoint].
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis.
The Ins and Outs of B Cells in Multiple Sclerosis.
Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG.
Autoimmune disease: SIRT1 inhibition suppresses multiple sclerosis.
Pharmacological treatment for memory disorder in multiple sclerosis.
[Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
Development of a patient-centred conceptual framework of health-related quality of life in neuromyelitis optica: a qualitative study.
The Significance of Matrix Metalloproteinases in the Immunopathogenesis and Treatment of Multiple Sclerosis.
Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
Let's rehabilitate cognitive rehabilitation in multiple sclerosis.
Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome.
Preliminary Observations on Sensitivity and Specificity of Magnetization Transfer Asymmetry for Imaging Myelin of Rat Brain at High Field.
Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis.
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
Pages
« first
‹ previous
…
697
698
699
700
701
702
703
704
705
…
next ›
last »